Description
A Nampt inhibitor (IC50s = 3-6 nM) that prevents NAD+ synthesis from nicotinamide; inhibits the viability of multiple B-cell acute lymphoblastic leukemia cell lines with nanomolar potency and improves survival in an orthotopic xenotransplant model of high-risk acute lymphoblastic leukemia in mice
Formal name: 4-[5-methyl-4-[[(4-methylphenyl)sulfonyl]methyl]-2-oxazolyl]-N-(3-pyridinylmethyl)-benzamide
Synonyms:
Molecular weight: 461.5
CAS: 894187-61-2
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Metabolism